1. Monkeypox Virus (MPV) Infection Public Health Alert SA Health, 21 May 2022 Monkeypox infection is caused by monkeypox virus. It is endemic in central and west Africa with cases outside Africa usually detected in returned travellers. As of 20 May 2022, 15 countries have reported 27 confirmed and 45 suspected cases of monkeypox. Several countries have reported cases in men who have sex with men...
SiREN (WA Sexual Health and Blood-borne Virus Applied Research and Evaluation Network), August 2021 Standard registrations for the 2021 Sexual Health + HIV&AIDS Conferences close this Sunday, August 22! Joint Australasian HIV&AIDS and Sexual Health Conferences will once again be hosted in a virtual format between 6 to 9 September, following the success of last year’s inaugural virtual...
ASHM, April 2021 Treatment with direct acting antivirals is easier than ever. This FREE course aims to provide Nurse Practitioners the skills and confidence to diagnose, assess, manage and treat hepatitis C. Online Training Session 1: Thursday 29 April, 7:00pm-9:00pm AEST (6.30 – 8.30 PM ACST) Online Training Session 2: Thursday 06 May, 7:00pm-9:00pm AEST (6.30 – 8.30 PM ACST) This...
ASHM, August 2020 This training aims to provide participants with the knowledge and confidence to pursue the management of HCV in their primary care setting. Primary care providers can play a critical role in the elimination of hepatitis C in Australia by 2030. This workshop will provide an overview of the management of HCV in primary care settings, including case finding, testing, patient...
ASHM, UPDATED ON: 14 April 2020 ASHM’s Taskforce on BBVs, Sexual Health and COVID-19 was established on 20 March 2020. It provides a timely opportunity for the BBV and sexual health sectors to discuss the scientific, clinical, BBV and sexual health service delivery and social implications of COVID-19, and provides consistent and evidence-based messaging to the health workforce, sector partners...
Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...